1. |
Cho BJ, Shin JY, Yu HG. Complications of pathologic myopia[J]. Eye Contact Lens, 2016, 42(1): 9-15. DOI: 10.1097/icl.0000000000000223.
|
2. |
You QS, Peng XY, Xu L, et al. Myopic maculopathy imaged by optical coherence tomography: the Beijing Eye Study[J]. Ophthalmology, 2014, 121(1): 220-224. DOI: 10.1016/j.ophtha.2013.06.013.
|
3. |
Lin CW, Ho TC, Yang CM. The development and evolution of full thickness macular hole in highly myopic eyes[J]. Eye (Lond), 2015, 29(3): 388-396. DOI: 10.1038/eye.2014.312.
|
4. |
Shimada N, Ohno-Matsui K, Baba T, et al. Natural course of macular retinoschisis in highly myopic eyes without macular hole or retinal detachment[J]. Am J Ophthalmol, 2006, 142(3): 497-500. DOI: 10.1016/j.ajo.2006.03.048.
|
5. |
Gaucher D, Haouchine B, Tadayoni R, et al. Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome[J]. Am J Ophthalmol, 2007, 143(3): 455-462. DOI: 10.1016/j.ajo.2006.10.053.
|
6. |
Zhao X, Ma W, Lian P, et al. Three-year outcomes of macular buckling for macular holes and foveoschisis in highly myopic eyes[J/OL]. Acta Ophthalmol, 2020, 98(4): e470-e478[2019-11-19].https://pubmed.ncbi.nlm.nih.gov/31742899/. DOI: 10.1111/aos.14305.
|
7. |
Kim KS, Lee SB, Lee WK. Vitrectomy and internal limiting membrane peeling with and without gas tamponade for myopic foveoschisis[J]. Am J Ophthalmol, 2012, 153(2): 320-326. DOI: 10.1016/j.ajo.2011.07.007.
|
8. |
Kwok AK, Lai TY. Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case-control study[J]. Br J Ophthalmol, 2003, 87(7): 885-889. DOI: 10.1136/bjo.87.7.885.
|
9. |
Kwok AK, Lai TY, Li WW, et al. Indocyanine green-assisted internal limiting membrane removal in epiretinal membrane surgery: a clinical and histologic study[J]. Am J Ophthalmol, 2004, 138(2): 194-199. DOI: 10.1016/j.ajo.2004.03.013.
|
10. |
Bando H, Ikuno Y, Choi JS, et al. Ultrastructure of internal limiting membrane in myopic foveoschisis[J]. Am J Ophthalmol, 2005, 139(1): 197-199. DOI: 10.1016/j.ajo.2004.07.027.
|
11. |
Al-Badawi AH, Abdelhakim MASE, Macky TA, et al. Efficacy of non-fovea-sparing ILM peeling for symptomatic myopic foveoschisis with and without macular hole[J]. Br J Ophthalmol, 2019, 103(2): 257-263. DOI: 10.1136/bjophthalmol-2017-311775.
|
12. |
Rizzo S, Giansanti F, Finocchio L, et al. Vitrectomy with internal limiting membrane peeling and air tamponade for myopic foveoschsis[J]. Retina, 2019, 39(11): 2125-2131. DOI: 10.1097/iae.0000000000002265.
|
13. |
Germano RA, Zacharias LC, Takahashi WY. Recurrent myopic foveoschisis: resolution after internal limiting membrane removal[J]. Arq Bras Oftalmol, 2015, 78(1): 44-46. DOI: 10.5935/0004-2749.20150012.
|
14. |
Sayanagi K, Ikuno Y, Tano Y. Reoperation for persistent myopic foveoschisis after primary vitrectomy[J]. Am J Ophthalmol, 2006, 141(2): 414-417. DOI: 10.1016/j.ajo.2005.09.009.
|
15. |
Kwok AK, Yeung CK, Lai TY, et al. Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells[J]. Br J Ophthalmol, 2004, 88(12): 1590-1594. DOI: 10.1136/bjo.2004.044537.
|
16. |
Díaz-Valverde A, Wu L. To peel or not to peel the internal limiting membrane in idiopathic epiretinal membranes[J]. Retina, 2018, 38(Suppl 1): S5-11. DOI: 10.1097/iae.0000000000001906.
|
17. |
Qi Y, Duan AL, Meng X, et al. Vitrectomy without inner limiting membrane peeling for macular retinoschisis in highly myopic eyes[J]. Retina, 2016, 36(5): 953-956. DOI: 10.1097/iae.0000000000000826.
|
18. |
Gui J, Ai L, Huang T. Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis[J]. BMC Ophthalmol, 2020, 20(1): 83. DOI: 10.1186/s12886-020-01354-8.
|
19. |
Meng B, Zhao L, Yin Y, et al. Internal limiting membrane peeling and gas tamponade for myopic foveoschisis: a systematic review and meta-analysis[J]. BMC Ophthalmol, 2017, 17(1): 166. DOI: 10.1186/s12886-017-0562-8.
|
20. |
Lee CL, Wu WC, Chen KJ, et al. Modified internal limiting membrane peeling technique (maculorrhexis) for myopic foveoschisis surgery[J/OL]. Acta Ophthalmol, 2017, 95(2): e128-e131[2016-07-20]. https://pubmed.ncbi.nlm.nih.gov/27320761/. DOI: 10.1111/aos.13115.
|
21. |
Ho TC, Chen MS, Huang JS, et al. Foveola nonpeeling technique in internal limiting membrane peeling of myopic foveoschisis surgery[J]. Retina, 2012, 32(3): 631-634. DOI: 10.1097/iae.0b013e31824d0a4b.
|
22. |
Shimada N, Sugamoto Y, Ogawa M, et al. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy[J]. Am J Ophthalmol, 2012, 154(4): 693-701. DOI: 10.1016/j.ajo.2012.04.013.
|
23. |
Jin H, Zhang Q, Zhao P. Fovea sparing internal limiting membrane peeling using multiple parafoveal curvilinear peels for myopic foveoschisis: technique and outcome[J]. BMC Ophthalmol, 2016, 16(1): 180. DOI: 10.1186/s12886-016-0356-4.
|
24. |
Kumar A, Ravani R, Mehta A, et al. Outcomes of microscope-integrated intraoperative optical coherence tomography-guided center-sparing internal limiting membrane peeling for myopic traction maculopathy: a novel technique[J]. Int Ophthalmol, 2018, 38(4): 1689-1696. DOI: 10.1007/s10792-017-0644-x.
|
25. |
Elwan MM, Abd Elghafar AE, Hagras SM, et al. Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis[J]. Eur J Ophthalmol, 2019, 29(1): 69-74. DOI: 10.1177/1120672117750059.
|
26. |
Wang L, Wang Y, Li Y, et al. Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis[J/OL]. Medicine (Baltimore), 2019, 98(9): e14710[2019-03-01]. https://pubmed.ncbi.nlm.nih.gov/30817612/. DOI: 10.1097/md.0000000000014710.
|
27. |
Iwasaki M, Miyamoto H, Okushiba U, et al. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy[J]. Jpn J Ophthalmol, 2020, 64(1): 13-21. DOI: 10.1007/s10384-019-00696-1.
|
28. |
Tian T, Jin H, Zhang Q, et al. Long-term surgical outcomes of multiple parfoveolar curvilinear internal limiting membrane peeling for myopic foveoschisis[J]. Eye (Lond), 2018, 32(11): 1783-1789. DOI: 10.1038/s41433-018-0178-0.
|
29. |
Lim SJ, Kwon YH, Kim SH, et al. Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis[J]. Graefe's Arch Clin Exp Ophthalmol, 2012, 250(11): 1573-1577. DOI: 10.1007/s00417-012-1983-y.
|
30. |
Ma IH, Hsieh YT, Yeh PT, et al. Long-term results and risk factors influencing outcome of gas tamponade for myopic foveoschisis with foveal detachment[J]. Eye (Lond), 2020, 34(2): 392-399. DOI: 10.1038/s41433-019-0555-3.
|
31. |
Jiang J, Yu X, He F, et al. Treatment of myopic foveoschisis with air versus perfluoropropane: a retrospective study[J]. Med Sci Monit, 2017, 23: 3345-3352. DOI: 10.12659/msm.901758.
|
32. |
Zhu X, Shen P, Li C, et al. Intravitreal gas injection with laser photocoagulation for highly myopic foveoschisis: technique and outcome[J]. Retina, 2019, 39(7): 1305-1311. DOI: 10.1097/iae.0000000000002145.
|
33. |
Ikuno Y, Sayanagi K, Soga K, et al. Foveal anatomical status and surgical results in vitrectomy for myopic foveoschisis[J]. Jpn J Ophthalmol, 2008, 52(4): 269-276. DOI: 10.1007/s10384-008-0544-8.
|
34. |
Kumagai K, Furukawa M, Ogino N, et al. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis[J]. Retina, 2010, 30(6): 874-880. DOI: 10.1097/IAE.0b013e3181c703fc.
|
35. |
Huang Y, Huang W, Ng DSC, et al. Risk facors for development of macular hole retinal detachment after pars plana vitrectomy for pathologic myopic foveoschisis[J]. Retina, 2017, 37(6): 1049-1054. DOI: 10.1097/iae.0000000000001322.
|
36. |
Lehmann M, Devin F, Rothschild PR, et al. Preoperative factors influencing visual recovery after vitrectomy for myopic foveoschisis[J]. Retina, 2019, 39(3): 594-600. DOI: 10.1097/iae.0000000000001992.
|
37. |
Baba T, Tanaka S, Maesawa A, et al. Scleral buckling with macular plombe for eyes with myopic macular retinoschisis and retinal detachment without macular hole[J]. Am J Ophthalmol, 2006, 142(3): 483-487. DOI: 10.1016/j.ajo.2006.04.046.
|
38. |
Alkabes M, Mateo C. Macular buckle technique in myopic traction maculopathy: a 16-year review of the literature and a comparison with vitreous surgery[J]. Graefe's Arch Clin Exp Ophthalmol, 2018, 256(5): 863-877. DOI: 10.1007/s00417-018-3947-3.
|
39. |
Shimada N, Tanaka Y, Tokoro T, et al. Natural course of myopic traction maculopathy and factors associated with progression or resolution[J]. Am J Ophthalmol, 2013, 156(5): 948-957. DOI: 10.1016/j.ajo.2013.06.031.
|
40. |
Liu B, Chen S, Li Y, et al. Comparison of macular buckling and vitrectomy for the treatment of macular schisis and associated macular detachment in high myopia: a randomized clinical trial[J/OL]. Acta Ophthalmol, 2020, 98(3): e266-e272[2019-11-17]. https://pubmed.ncbi.nlm.nih.gov/31736279/. DOI: 10.1111/aos.14260.
|
41. |
Wu PC, Sheu JJ, Chen YH, et al. Gore-tex vascular graft for macular buckling in high myopia eyes[J]. Retina, 2017, 37(7): 1263-1269. DOI: 10.1097/iae.0000000000001376.
|
42. |
Cacciamani A, Lazzeri S, Rossi T, et al. Adjustable macular buckling for full-thickness macular hole with foveoschisis in highly myopic eyes[J]. Retina, 2016, 36(4): 709-716. DOI: 10.1097/iae.0000000000000802.
|
43. |
Liu B, Ma W, Li Y, et al. Macular buckling buckling using a three-armed silicone capsule for foveoschisis associated with high myopia[J]. Retina, 2016, 36(10): 1919-1926. DOI: 10.1097/iae.0000000000001014.
|
44. |
Mateo C, Burés-Jelstrup A, Navarro R, et al. Macular buckling for eyes with myopic foveoschisis secondary to posterior staphyloma[J]. Retina, 2012, 32(6): 1121-1128. DOI: 10.1097/IAE.0b013e31822e5c32.
|
45. |
Zhu Z, Ji X, Zhang J, et al. Posterior scleral reinforcement in the treatment of macular retinoschisis in highly myopic patients[J]. Clin Exp Ophthalmol, 2009, 37(7): 660-663. DOI: 10.1111/j.1442-9071.2009.02111.x.
|
46. |
Ji X, Wang J, Zhang J, et al. The effect of posterior scleral reinforcement for high myopia macular splitting[J]. J Int Med Res, 2011, 39(2): 662-666. DOI: 10.1177/147323001103900236.
|
47. |
Sun CB, Xue AQ, Yao K. Is posterior scleral reinforcement sufficient for the treatment of myopic foveoschisis?[J]. Clin Exp Ophthalmol, 2010, 38(4): 429-430. DOI: 10.1111/j.1442-9071.2010.02287_1.x.
|
48. |
Parolini B, Frisina R, Pinackatt S, et al. Indications and results of a new l-shaped macular buckle to support a posterior staphyloma in high myopia[J]. Retina, 2015, 35(12): 2469-2482. DOI: 10.1097/iae.0000000000000613.
|
49. |
El Rayes EN. Supra choroidal buckling in managing myopic vitreoretinal interface disorders: 1-year data[J]. Retina, 2014, 34(1): 129-135. DOI: 10.1097/IAE.0b013e31828fcb77.
|
50. |
Qi Y, Duan AL, You QS, et al. Posterior scleral reinforcement and vitrectomy for myopic foveoschisis in extreme myopia[J]. Retina, 2015, 35(2): 351-357. DOI: 10.1097/iae.0000000000000313.
|
51. |
Cao K, Wang J, Zhang J, et al. The effectiveness and safety of posterior scleral reinforcement with vitrectomy for myopic foveoschisis treatment: a systematic review and meta-analysis[J]. Graefe's Arch Clin Exp Ophthalmol, 2020, 258(2): 257-271. DOI: 10.1007/s00417-019-04550-5.
|